Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 3, 2023
Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver MetastasesHarufumi Maki, Bradford J Kim, Yoshikuni Kawaguchi, et al.Clinical Immunology (Orlando, Fla.)|August 16, 2022
Immunologic and dose dependent effects of rapamycin and its evolving role in chemopreventionAnne E O'Shea, Franklin A Valdera, Daniel Ensley, et al.Journal of the American College of Surgeons|January 27, 2026
Surgical Trainee Familiarity and Knowledge of the Commission on Cancer (CoC) Operative Standards: A National Survey StudyAlison S Baskin, Elizabeth C Funk, Jack W Sample, et al.Frontiers in Immunology|March 24, 2023
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trialsPatrick M McCarthy, Franklin A Valdera, Todd R Smolinsky, et al.Clinical Immunology (Orlando, Fla.)|January 24, 2021
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancerR Connor Chick, G Travis Clifton, Diane F Hale, et al.Annals of Surgical Oncology|June 28, 2019
Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery PatientsTimothy E Newhook, Whitney L Dewhurst, Timothy J Vreeland, et al.Cancer Medicine|July 6, 2019
Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patientsTommy A Brown, Kevin Byrd, Timothy J Vreeland, et al.Annals of Surgical Oncology|February 28, 2021
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary AnalysisTimothy J Vreeland, Guy T Clifton, Diane F Hale, et al.Annals of Surgery|June 11, 2025
First National Effort to Optimize the Performance of Cancer Surgery by the American College of Surgeons Commission on Cancer and Cancer Surgery Standards Program: Early Results After Implementation of the Operative StandardsMatthew H G Katz, Amanda B Francescatti, Timothy W Mullett, et al.Journal of Surgical Oncology|October 6, 2023
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing mattersFranklin A Valdera, Anne E O'Shea, Todd R Smolinsky, et al.Pageof 8